MedTrace Logo

Valerian for Conscious Sedation in Patients Submitted to Impacted Lower Third Molars Surgery

NCT01612130 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2012-06-06

No results posted yet for this study

Summary

The aim of the present study was to evaluate the efficacy of Valeriana officinalis L. 100 mg in single oral doses one hour preoperative as conscious sedation during the impacted lower third molar surgery.

Conditions

  • Dental Anxiety
  • Blood Pressure
  • Heart Rate

Interventions

DRUG

100 mg of Valeriana officinalis L

A single dose of 100 mg of Valeriana officinalis L., 1 hour prior to surgical procedures

DRUG

Placebo 100mg

A single dose of 100 mg of placebo orally, 1 hour prior to surgical procedures

Sponsors & Collaborators

  • University of Campinas, Brazil

    collaborator OTHER

  • Federal University of the Valleys of Jequitinhonha and Mucuri

    lead OTHER

Principal Investigators

  • Marcos Pinheiro, PhD · Federal University of the Valleys of Jequitinhonha and Mucuri

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-03-31
Primary Completion
2003-08-31
Completion
2003-08-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01612130 on ClinicalTrials.gov